- Home
- Industry Reports
- Biotechnology
- Healthcare
- Cancer Therapies Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Cancer therapies are drugs that are actively involved in reducing or blocking the growth of cancer by interacting with specific molecules which are responsible for the increase, progression, and spread of cancerous cells. Cancer therapy is different from standard chemotherapy treatment as these therapies target only cancerous cells without affecting the healthy cells. Cancer therapies market is expected to grow at a significant rate over the forecast period and is anticipated to perform well due to awareness regarding chronic diseases and cancer types. Many industries and firms are trying to develop new technologies and make advancements to improve the market.
Cancer Therapies Market Segments size & growth:
The market is valued at USD XX million in2017 and is expected to reach USD XX million by 2024 at a CAGR of XX%. The cancer therapies market growth is mainly due to rise in cancer incidences and access to modern therapeutics, the population of aged people, efficiency and high price manufacturers and innovations and increases in awareness regarding molecular diagnostic techniques. These are the significant factors influencing the market growth.
Cancer Therapies Market Segment share:
Cancer therapies Market is segmented into treatment type, cancer type, therapeutics, application, and chemotherapy. Targeted cancer is holding the most significant share in the market due to the increasing prevalence of various types of cancers and awareness regarding the molecular diagnostics. By treatment type, the market is in surgery, chemotherapy, radiation therapy, targeted therapy, immune therapy, hormonal therapy, hyperthermia and stem cell transplant. By cancer type, the market is in blood therapy, bone cancer, brain cancer, breast cancer, endocrine cancer, eye cancer, gynecologic cancer, head and neck cancer, respiratory and skin cancer. By application, the market is into Nasal spray, pills or tablets, skin gel, skin patches, vaginal creams or vaginal tablets and vaginal ring. On the basis chemotherapy, type of agents and chemotherapy regimens are the segments. Geographically, North America is occupying the most significant share in the market, especially in globally targeted therapies demand due to more number of market players and higher patient awareness levels.
Cancer Therapies Market Trends:
- Genentech signed an agreement to acquire tanox a biotechnology company.
- Genentech and tanox are trying to collaborate with Novartis to develop and commercialise Xolair and anti-IgE monoclonal antibody.
- Roche and Genentech announced the acquisition of Genentech and Genentech became a wholly owned member of Roche group.
Cancer Therapies Market Research Reports Include:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- The principal market players are:
- Novartis
- Astrazeneca Plc
- Genentech Inc.
- Chugai pharmaceutical co Ltd
- GlaxoSmithKline PLC
1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Rise in cancer incidences and modern therapeutics.
4.1.2 Inclination in Aging population.
4.1.3 Efficiency and high price magnetise manufacturers.
4.1.4. Innovations and improvements to promote the market growth.
4.2. Restraints
4.2.1 High price therapies.
4.2.2 Changes in reimbursement processes.
4.3. Opportunities
4.3.1. Awareness regarding molecular diagnostics techniques.
4.3.2. Insurance coverage, aids in revenue growth of cancer therapies.
4.4. Challenges
4.4.1 Challenges encountered in clinical trials are retraining cancer therapy market.
5. Global Cancer Therapies Market – By Treatment Type
5.1 Introduction
5.2 Surgery
5.3 Chemotherapy
5.4 Radiation Therapy
5.5 Targeted Therapy
5.6 Immunotherapy (Biologic Therapy)
5.7 Hormonal Therapy
5.8 Hyperthermia
5.9 Stem Cell Transplant
5.10 Signal Transduction Inhibitors
5.11 Gene Expression Modulators
5.12 Apoptosis Inducers
5.13 Angiogenesis Inhibitors
5.14 Others
6. Global Cancer Therapies Market – By Cancer Type
6.1 Introduction
6.2 Blood Cancer
6.3 Bone Cancer
6.4 Brain Cancer
6.5 Breast Cancer
6.6 Digestive/ Gastrointestinal Cancer
6.7 Endocrine Cancer
6.8 Eye Cancer
6.9 Genitourinary Cancer
6.10 Gynecologic Cancer
6.11 Head & Neck Cancers
6.12 Respiratory/Lung Cancer
6.13 Skin Cancer
7. Global Cancer Therapies Market – By Targeted cancer therapeutics
7.1 Introduction
7.2 Targeted Cancer Therapeutics
7.3 Hormone Therapies
7.4 Signal Transduction Inhibitors
7.5 Gene Expression Modulators
7.6 Apoptosis Inducers
7.7 Angiogenesis Inhibitors
7.8 Immunotherapies
7.8.1 Monoclonal Antibodies
7.8.1.1 Naked Monoclonal Antibodies
7.8.1.2 Conjugated Monoclonal Antibodies
7.8.1.2.1 Radiolabeled Antibodies
7.8.1.2.2 Chemolabeled Antibodies
7.9 Cancer Vaccines
7.9.1 Vaccines to Help Prevent Cancer
7.9.2 Vaccines to Help Treat Cancer
7.10 Non-Specific Immunotherapies
7.10.1 Interferons
7.10.2 Interleukins.
8. Global Cancer Therapies Market – By Application
8.1 Introduction
8.2 Nasal Spray
8.3 Pills or Tablets, Taken By Mouth
8.4 Skin Gel
8.5 Skin Patches
8.6 Vaginal Creams or Vaginal Tablets
8.7 Vaginal Ring
9. Global Cancer Therapies Market – By Technology
9.1 Introduction
9.2 Types of Agents
9.2.1 Alkylating Agents
9.2.2 Anti-Metabolites
9.2.3 Anti-Microtubule Agents
9.2.4 Topoisomerase Inhibitors
9.2.5 Cytotoxic Antibiotics
9.3 Chemotherapy Regimens
9.3.1 Breast Cancer
9.3.2 Hodgkin’s Disease
9.3.3 Germ Cell Tumor
9.3.4 Stomach Cancer
9.3.5 Bladder Cancer
9.3.6 Lung Cancer
10. Global Cancer Therapies Market – By Geography
10.1 Introduction
10.2 North America
10.2.1 United States
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 France
10.3.2 Germany
10.3.3 Italy
10.3.4 UK
10.3.5 Spain
10.3.6 Russia
10.3.7 Rest of Europe
10.4 Asia-pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia & New Zealand
10.4.5 South Korea
10.4.6 Rest of APAC
10.5 South America
10.5.1 Introduction
10.5.2 Brazil
10.5.3 Argentina
10.5.4 Others
10.6 The Middle East and Africa
10.6.1 Introduction
10.6.2 Middle East
10.6.3 Africa
11. Global Cancer Therapies Market – Company Profiles
11.1 Novartis
11.2 AstraZeneca Plc
11.3 Genentech Inc.
11.4 Chugai pharmaceutical co Ltd
11.5 GlaxoSmithKline plc
11.6 GPC Biotech Ag
11.7 Bayer
11.8 Pfizer
11.9 Sanofi
11.10 Osi pharmaceutical
11.11 Abbott laboratories
11.12 Aveo pharmaceuticals
11.13 Hospira Inc.,
11.14 Boehringer Ingelheim GmbH
12. Global Cancer Therapies Market – Competitive Landscape
12.1 Market Share Analysis
12.2 Strategies Adopted by top companies
12.3 Merges, Acquisitions, Collaborations & Agreements
13. Market Insights
13.1 Industry Experts Insights
13.2 Analysts Opinions
13.3 Investment Opportunities
- Appendix
14.1 List of tables
14.2 List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,520.07 - €7,560.20
- INR: ₹225,090.13 - ₹675,270.40
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,158.26 - £6,474.78
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Cancer therapies are drugs that are actively involved in reducing or blocking the growth of cancer by interacting with specific molecules which are responsible for the increase, progression, and spread of cancerous cells. Cancer therapy is different from standard chemotherapy treatment as these therapies target only cancerous cells without affecting the healthy cells. Cancer therapies market is expected to grow at a significant rate over the forecast period and is anticipated to perform well due to awareness regarding chronic diseases and cancer types. Many industries and firms are trying to develop new technologies and make advancements to improve the market.
Cancer Therapies Market Segments size & growth:
The market is valued at USD XX million in2017 and is expected to reach USD XX million by 2024 at a CAGR of XX%. The cancer therapies market growth is mainly due to rise in cancer incidences and access to modern therapeutics, the population of aged people, efficiency and high price manufacturers and innovations and increases in awareness regarding molecular diagnostic techniques. These are the significant factors influencing the market growth.
Cancer Therapies Market Segment share:
Cancer therapies Market is segmented into treatment type, cancer type, therapeutics, application, and chemotherapy. Targeted cancer is holding the most significant share in the market due to the increasing prevalence of various types of cancers and awareness regarding the molecular diagnostics. By treatment type, the market is in surgery, chemotherapy, radiation therapy, targeted therapy, immune therapy, hormonal therapy, hyperthermia and stem cell transplant. By cancer type, the market is in blood therapy, bone cancer, brain cancer, breast cancer, endocrine cancer, eye cancer, gynecologic cancer, head and neck cancer, respiratory and skin cancer. By application, the market is into Nasal spray, pills or tablets, skin gel, skin patches, vaginal creams or vaginal tablets and vaginal ring. On the basis chemotherapy, type of agents and chemotherapy regimens are the segments. Geographically, North America is occupying the most significant share in the market, especially in globally targeted therapies demand due to more number of market players and higher patient awareness levels.
Cancer Therapies Market Trends:
- Genentech signed an agreement to acquire tanox a biotechnology company.
- Genentech and tanox are trying to collaborate with Novartis to develop and commercialise Xolair and anti-IgE monoclonal antibody.
- Roche and Genentech announced the acquisition of Genentech and Genentech became a wholly owned member of Roche group.
Cancer Therapies Market Research Reports Include:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- The principal market players are:
- Novartis
- Astrazeneca Plc
- Genentech Inc.
- Chugai pharmaceutical co Ltd
- GlaxoSmithKline PLC
1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Rise in cancer incidences and modern therapeutics.
4.1.2 Inclination in Aging population.
4.1.3 Efficiency and high price magnetise manufacturers.
4.1.4. Innovations and improvements to promote the market growth.
4.2. Restraints
4.2.1 High price therapies.
4.2.2 Changes in reimbursement processes.
4.3. Opportunities
4.3.1. Awareness regarding molecular diagnostics techniques.
4.3.2. Insurance coverage, aids in revenue growth of cancer therapies.
4.4. Challenges
4.4.1 Challenges encountered in clinical trials are retraining cancer therapy market.
5. Global Cancer Therapies Market – By Treatment Type
5.1 Introduction
5.2 Surgery
5.3 Chemotherapy
5.4 Radiation Therapy
5.5 Targeted Therapy
5.6 Immunotherapy (Biologic Therapy)
5.7 Hormonal Therapy
5.8 Hyperthermia
5.9 Stem Cell Transplant
5.10 Signal Transduction Inhibitors
5.11 Gene Expression Modulators
5.12 Apoptosis Inducers
5.13 Angiogenesis Inhibitors
5.14 Others
6. Global Cancer Therapies Market – By Cancer Type
6.1 Introduction
6.2 Blood Cancer
6.3 Bone Cancer
6.4 Brain Cancer
6.5 Breast Cancer
6.6 Digestive/ Gastrointestinal Cancer
6.7 Endocrine Cancer
6.8 Eye Cancer
6.9 Genitourinary Cancer
6.10 Gynecologic Cancer
6.11 Head & Neck Cancers
6.12 Respiratory/Lung Cancer
6.13 Skin Cancer
7. Global Cancer Therapies Market – By Targeted cancer therapeutics
7.1 Introduction
7.2 Targeted Cancer Therapeutics
7.3 Hormone Therapies
7.4 Signal Transduction Inhibitors
7.5 Gene Expression Modulators
7.6 Apoptosis Inducers
7.7 Angiogenesis Inhibitors
7.8 Immunotherapies
7.8.1 Monoclonal Antibodies
7.8.1.1 Naked Monoclonal Antibodies
7.8.1.2 Conjugated Monoclonal Antibodies
7.8.1.2.1 Radiolabeled Antibodies
7.8.1.2.2 Chemolabeled Antibodies
7.9 Cancer Vaccines
7.9.1 Vaccines to Help Prevent Cancer
7.9.2 Vaccines to Help Treat Cancer
7.10 Non-Specific Immunotherapies
7.10.1 Interferons
7.10.2 Interleukins.
8. Global Cancer Therapies Market – By Application
8.1 Introduction
8.2 Nasal Spray
8.3 Pills or Tablets, Taken By Mouth
8.4 Skin Gel
8.5 Skin Patches
8.6 Vaginal Creams or Vaginal Tablets
8.7 Vaginal Ring
9. Global Cancer Therapies Market – By Technology
9.1 Introduction
9.2 Types of Agents
9.2.1 Alkylating Agents
9.2.2 Anti-Metabolites
9.2.3 Anti-Microtubule Agents
9.2.4 Topoisomerase Inhibitors
9.2.5 Cytotoxic Antibiotics
9.3 Chemotherapy Regimens
9.3.1 Breast Cancer
9.3.2 Hodgkin’s Disease
9.3.3 Germ Cell Tumor
9.3.4 Stomach Cancer
9.3.5 Bladder Cancer
9.3.6 Lung Cancer
10. Global Cancer Therapies Market – By Geography
10.1 Introduction
10.2 North America
10.2.1 United States
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 France
10.3.2 Germany
10.3.3 Italy
10.3.4 UK
10.3.5 Spain
10.3.6 Russia
10.3.7 Rest of Europe
10.4 Asia-pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia & New Zealand
10.4.5 South Korea
10.4.6 Rest of APAC
10.5 South America
10.5.1 Introduction
10.5.2 Brazil
10.5.3 Argentina
10.5.4 Others
10.6 The Middle East and Africa
10.6.1 Introduction
10.6.2 Middle East
10.6.3 Africa
11. Global Cancer Therapies Market – Company Profiles
11.1 Novartis
11.2 AstraZeneca Plc
11.3 Genentech Inc.
11.4 Chugai pharmaceutical co Ltd
11.5 GlaxoSmithKline plc
11.6 GPC Biotech Ag
11.7 Bayer
11.8 Pfizer
11.9 Sanofi
11.10 Osi pharmaceutical
11.11 Abbott laboratories
11.12 Aveo pharmaceuticals
11.13 Hospira Inc.,
11.14 Boehringer Ingelheim GmbH
12. Global Cancer Therapies Market – Competitive Landscape
12.1 Market Share Analysis
12.2 Strategies Adopted by top companies
12.3 Merges, Acquisitions, Collaborations & Agreements
13. Market Insights
13.1 Industry Experts Insights
13.2 Analysts Opinions
13.3 Investment Opportunities
- Appendix
14.1 List of tables
14.2 List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.